HemaCare Co. (OTCMKTS:HEMA – Get Free Report)’s share price was up 0.6% on Wednesday . The company traded as high as $25.31 and last traded at $25.31. Approximately 5,400 shares were traded during trading, a decline of 86% from the average daily volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Stock Up 0.6 %
The stock has a fifty day moving average price of $25.31 and a 200-day moving average price of $25.31.
HemaCare Company Profile
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Further Reading
- Five stocks we like better than HemaCare
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- S&P 500 Earnings Set to Shine: January’s Critical Market Test
- What is the Euro STOXX 50 Index?
- Reddit Stock Dominated 2024—Why the Rally Isn’t Over Yet
- 3 Small Caps With Big Return Potential
- Investing in Sustainable Solutions: 2 Top Water Tech Stocks
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
